31 July 2018
Novartis receives European licence for Aimovig® (erenumab), the first treatment designed specifically for the prevention of migraine
30 July 2018
Chrystalina Antoniades of the NeuroMetrology Lab delivered a session to these summer school delegates about her work on change blindness with the Ashmolean.
27 June 2018
Our Department collaborated with Oxford BioDynamics and Massachusetts General Hospital, Harvard Medical School.
21 June 2018
Aarti Jagannath presents the first in a new series about how the NHS changed our world
18 June 2018
The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium academically led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.
9 February 2018
Remember trying to spot the subtle differences between pictures as a child? It kept us quiet for hours! Neuroscientists including Chrystalina Antoniades have been working with staff at Oxford’s Ashmolean Museum on some interesting ‘spot the difference’ experiments, to try and find out more about how we perceive things.
18 September 2017
Researchers from the teams of Andrea Németh (NDCN) and Esther Becker (DPAG) have published an important paper reporting dominant mutations that cause a new type of cerebellar ataxia, Spinocerebellar Ataxia type 44.
10 April 2017
New research project could enable novel therapeutic approaches in Alzheimer’s and Parkinson’s diseases.
17 March 2017
Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine.